Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Int J Biol Macromol ; 267(Pt 1): 131336, 2024 May.
Artículo en Inglés | MEDLINE | ID: mdl-38583840

RESUMEN

Fucoidan, a sulfated polysaccharide of marine origin found in brown algae and sea cucumbers, has been identified as a neuroprotective compound. In this study, a novel fucoidan MF4 was extracted from Fucus vesiculosus and isolated using Q-Sepharose fast-flow ion-exchange chromatography. The physicochemical properties of MF4 were characterized. MF4 is primarily composed of fucose, xylose, galactose, glucose, and mannose in a molar ratio of 12.3: 4.9: 1.1: 1.0: 1.1, with an average molecular weight of 67.7 kDa. Notably, MF4 demonstrated suppression of LLC tumor growth in vivo. RNA-sequencing analysis revealed that MF4 enhanced the expression of type I interferon-associated downstream genes in macrophages. Furthermore, MF4 increased the levels of phosphorylated TBK1 and IRF3 proteins in vitro. By activating the STING-TBK1-IRF3 signaling pathway, MF4 may enhance the antitumor activity of macrophages. Taken together, MF4 has promising potential as an antitumor and immunomodulatory agent.


Asunto(s)
Carcinoma Pulmonar de Lewis , Factor 3 Regulador del Interferón , Polisacáridos , Proteínas Serina-Treonina Quinasas , Transducción de Señal , Polisacáridos/farmacología , Polisacáridos/química , Polisacáridos/aislamiento & purificación , Animales , Ratones , Factor 3 Regulador del Interferón/metabolismo , Transducción de Señal/efectos de los fármacos , Proteínas Serina-Treonina Quinasas/metabolismo , Carcinoma Pulmonar de Lewis/tratamiento farmacológico , Carcinoma Pulmonar de Lewis/metabolismo , Carcinoma Pulmonar de Lewis/patología , Proteínas de la Membrana/metabolismo , Proteínas de la Membrana/genética , Macrófagos/efectos de los fármacos , Macrófagos/metabolismo , Antineoplásicos/farmacología , Antineoplásicos/química , Línea Celular Tumoral , Células RAW 264.7
2.
J Craniofac Surg ; 35(4): e350-e351, 2024 Jun 01.
Artículo en Inglés | MEDLINE | ID: mdl-38456615

RESUMEN

Cervical ganglioneuroma combined with neurofibromatosis type I is very rare. This article reports a case of a 21-year-old male patient with a rare presentation of cervical ganglioneuroma and neurofibromatosis type I. In this patient, the tumors on both sides of the cervical spine were surgically removed with good results. The effects and advantages of surgery when both diseases coexist are discussed, as well as further investigation into possible causal relationships between these two pathologies.


Asunto(s)
Ganglioneuroma , Neurofibromatosis 1 , Humanos , Ganglioneuroma/cirugía , Ganglioneuroma/patología , Ganglioneuroma/diagnóstico por imagen , Neurofibromatosis 1/complicaciones , Neurofibromatosis 1/cirugía , Masculino , Adulto Joven , Vértebras Cervicales/cirugía , Vértebras Cervicales/diagnóstico por imagen , Imagen por Resonancia Magnética , Tomografía Computarizada por Rayos X , Diagnóstico Diferencial
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...